HbA1c and the risk of developing peripheral neuropathy in childhood-onset type 1 diabetes: A follow-up study over 3 decadesShow others and affiliations
2024 (English)In: Diabetes/Metabolism Research Reviews, ISSN 1520-7552, E-ISSN 1520-7560, Vol. 40, no 5, article id e3825Article in journal (Refereed) Published
Abstract [en]
AIMS: We have evaluated long-term weighted mean HbA1c (wHbA1c), HbA1c variability, diabetes duration, and lipid profiles in relation to the development of diabetic peripheral neuropathy (DPN), nephropathy, and retinopathy in childhood-onset type 1 diabetes.
MATERIALS AND METHODS: In a longitudinal cohort study, 49 patients (21 women) with childhood-onset type 1 diabetes were investigated with neurophysiological measurements, blood tests, and clinical examinations after a diabetes duration of 7.7 (±3.3) years (baseline) and followed with repeated examinations for 30.6 (±5.2) years. We calculated wHbA1c by integrating the area under all HbA1c values since the diabetes diagnosis. Lipid profiles were analysed in relation to the presence of DPN. Long-term fluctuations of HbA1c variability were computed as the standard deviation of all HbA1c measurements. Data regarding the presence of other diabetes complications were retrieved from medical records.
RESULTS: In this follow-up study, 51% (25/49) of the patients fulfilled electrophysiological criteria for DPN. In nerve conduction studies, there was a deterioration in the amplitudes and conduction velocities for the median, peroneal, and sural nerves over time. Patients with DPN had a longer duration of diabetes, higher wHbA1c, and increased HbA1c variability. The lowest wHbA1c value associated with the development of DPN was 62 mmol/mol (7.8%). The presence of albuminuria and retinopathy was positively correlated with the presence of neuropathy.
CONCLUSIONS: More than half of the patients had developed DPN after 30 years. None of the patients who developed DPN had a wHbA1c of less than 62 mmol/mol (7.8%).
Place, publisher, year, edition, pages
John Wiley & Sons, 2024. Vol. 40, no 5, article id e3825
Keywords [en]
HbA1c target, cohort study, longitudinal study, peripheral neuropathy, type 1 diabetes
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-114254DOI: 10.1002/dmrr.3825ISI: 001248200100001PubMedID: 38878301Scopus ID: 2-s2.0-85196248140OAI: oai:DiVA.org:oru-114254DiVA, id: diva2:1871178
Funder
Linköpings universitetMedical Research Council of Southeast Sweden (FORSS), RÖ 697211; RÖ-799001; RÖ899391
Note
Financial support was received from Linköping University, Sweden, ALF grants (Swedish governmental funding of clinical research), and the Medical Research Council of Southeast Sweden.
2024-06-172024-06-172025-01-20Bibliographically approved